Determining the efficacy of dietary phytochemicals in cancer prevention

M M Manson1, B E Foreman, L M Howells

  • 1Cancer Biomarkers and Prevention Group, Department of Cancer Studies and Molecular Medicine, Biocentre, University of Leicester, Leicester LE1 7RH, U.K. mmm2@le.ac.uk

Insights

Dietary phytochemicals show promise in cancer prevention and treatment by targeting damaged cells. Further research is needed to understand their mechanisms and develop effective biomarkers for these natural compounds.

Area of Science:

  • Nutritional biochemistry
  • Cancer biology
  • Pharmacology

Background:

  • Dietary phytochemicals are increasingly recognized for their potential therapeutic effects.
  • Cancer involves deregulated signaling pathways, compromised cell checkpoints, and inhibited apoptosis.
  • Targeting cancer cells selectively while sparing healthy cells is a key goal in oncology.

Purpose of the Study:

  • To explore the potential of dietary phytochemicals in cancer chemoprevention and combination therapy.
  • To investigate the mechanisms by which phytochemicals interact with cellular pathways in cancer.
  • To highlight the need for developing reliable biomarkers for phytochemical efficacy.

Main Methods:

  • Review of existing scientific literature on dietary phytochemicals and cancer.
  • Analysis of cellular signaling pathways affected by phytochemicals.
  • Discussion of potential biomarker strategies for phytochemical research.

Main Results:

  • Phytochemicals demonstrate the ability to modulate deregulated signaling pathways in cancer cells.
  • These compounds can potentially reinstate checkpoint pathways and induce apoptosis in damaged cells.
  • A key finding is their minimal impact on healthy cells, suggesting selectivity.

Conclusions:

  • Dietary phytochemicals possess ideal characteristics for chemopreventive and anticancer strategies.
  • Substantial research is warranted to harness their biological activities for disease prevention and treatment.
  • Further investigation into their mode of action and novel biomarker development is crucial.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...